BSE filing, NSE: MAWANASUG. Summary written from the filing by ALFA Finder's alert engine.
Mawana Sugars Ltd: key numbers
- Share price
- ₹148.00
- Market cap
- ₹578.9 Cr
- Revenue (annual)
- ₹1,571 Cr
- Net profit (annual)
- ₹37.09 Cr
- P/E (TTM)
- 21.0×Sector 26.8×
- Promoter holding
- 63.49%+0.00% QoQ
- FII holding
- 0.72%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mawana Sugars Ltd
All →Mawana Sugars Legal & Regulatory
Mawana Sugars successfully contested a tax demand. The GST (Appeals) authority set aside the tax and penalty demand totaling approximately Rs. 0.0966 Crore.
- Value
- ₹0.10 Cr
Mawana Sugars Price Movement Clarification
Mawana Sugars clarified that the recent spurt in share volume is market-driven and not linked to any undisclosed material information or company events.
Mawana Sugars Annual General Meeting
Mawana Sugars shareholders passed both postal ballot resolutions reappointing an independent director and approving MD remuneration. The scrutinizer confirmed requisite majority on 18 September 2026.
Mawana Sugars Legal & Regulatory
Mawana Sugars received a GST audit notice from the Joint Commissioner, Meerut, demanding Rs. 12.94 Lakhs. The company intends to file an appeal against this demand.
- Value
- ₹0.13 Cr
Mawana Sugars Acquisition
Mawana Sugars announced that the NCLT Delhi Bench sanctioned the Scheme of Amalgamation between Mawana Foods Private Limited and Mawana Sugars Limited.
Mawana Sugars Price Movement Clarification
Mawana Sugars clarified that recent stock price movements are purely market-driven. The company confirmed it has no undisclosed price-sensitive information or pending announcements for investors.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.